NCT00636961View on ClinicalTrials.gov

An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Indacaterol 300μg

300μg indacaterol maleate inhalation powder in hard gelatin capsules administered via Concept1 inhalation device

DRUG

Placebo

Matching placebo devices and hard gelatin capsules

Trial Locations (3)

Unknown

Novartis Investigator Site, Berlin

Novartis Investigator Site, Mönchengladbach

Novartis Investigator Site, Wiesbaden

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00636961 - An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD) | Biotech Hunter | Biotech Hunter